|
|
Article: Sucampo Adds Chief Operating Officer and Names New Presidents at Americas and European Subsidiaries.
- Article from:
- Biotech Week
- Article date:
- September 30, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) announced the appointment of James J. Egan as Chief Operating Officer, Sucampo Pharmaceuticals, Inc., a newly-created position, effective September 15, 2009, reporting to Ryuji Ueno, M.D., Ph.D., Ph.D., Chair, and Chief Executive Officer of Sucampo Pharmaceuticals, Inc (see also Sucampo Pharmaceuticals, Inc.).
Sucampo also announced that Stanley G. Miele was promoted to President of Sucampo Pharma Americas, Inc., (SPA) and David Dodds was promoted to President of Sucampo Pharma Europe, Ltd. (SPE), effective immediately. Messrs. Dodds and Miele succeed Dr. Ueno in those positions and will report to Mr. Egan. Dr. Ueno ...
Related newspaper, magazine, and journal articles:
|
|
Article: Sucampo Pharmaceuticals Limited Appoints New Head ...
Business Wire;
September 2, 2008 ;
700+ words
... ... BETHESDA, MD -- Sucampo Pharmaceuticals, Inc. (NASDAQ ... Ueda as Senior Vice President, Business ... Officer of Sucampo Pharmaceuticals, Inc. and ... Officer of Sucampo Pharmaceuticals, Inc., said ...
|
|